H. Lee Moffitt Cancer Center and Research Institute, Inc is a clinical research site located in Tampa, Florida, United States 33612-9497.
Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.
H. Lee Moffitt Cancer Center and Research Institute, Inc has participated in 11 clinical trials with 4 currently active.
Therapeutic areas: Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV, Uveal Melanoma.
Sponsors: EMD Serono Research & Development Institute, Inc., Immunocore Ltd, Bicara Therapeutics.
Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
H. Lee Moffitt Cancer Center and Research Institute, Inc has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
H. Lee Moffitt Cancer Center and Research Institute, Inc has 11 clinical trials on record, with 4 currently active. Their work covers Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV, Uveal Melanoma.
Yes — H. Lee Moffitt Cancer Center and Research Institute, Inc holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.